KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Assets Average (2016 - 2025)

TherapeuticsMD (TXMD) has disclosed Assets Average for 14 consecutive years, with $38.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Assets Average fell 3.14% year-over-year to $38.6 million, compared with a TTM value of $38.6 million through Sep 2025, down 3.14%, and an annual FY2024 reading of $41.1 million, down 38.6% over the prior year.
  • Assets Average was $38.6 million for Q3 2025 at TherapeuticsMD, up from $38.4 million in the prior quarter.
  • Across five years, Assets Average topped out at $291.6 million in Q1 2023 and bottomed at $38.4 million in Q2 2025.
  • Average Assets Average over 5 years is $122.1 million, with a median of $112.2 million recorded in 2022.
  • The sharpest move saw Assets Average soared 95.45% in 2023, then crashed 85.36% in 2024.
  • Year by year, Assets Average stood at $189.5 million in 2021, then plummeted by 40.82% to $112.2 million in 2022, then crashed by 58.19% to $46.9 million in 2023, then decreased by 16.45% to $39.2 million in 2024, then dropped by 1.53% to $38.6 million in 2025.
  • Business Quant data shows Assets Average for TXMD at $38.6 million in Q3 2025, $38.4 million in Q2 2025, and $38.5 million in Q1 2025.